Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CFSAN Constituent Updates

CFSAN Constituent Updates Home
          Food
          News & Events from CFSAN
          CFSAN Constituent Updates
          Reckitt/Mead Johnson Nutrition Voluntarily Recalls Certain Nutramigen Hypoallergenic Powdered Infant Formula ProductsCFSAN Constituent Updates Reckitt/Mead Johnson Nutrition Voluntarily Recalls Certain Nutramigen Hypoallergenic Powdered Infant Formula Products
  
  	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    Printen español

What’s New

January 10, 2024

Products produced during the same finished product campaign as the U.S.-recalled product were distributed in at least the following countries: Argentina, Belgium, Belize, Canada, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Ireland, Israel, Jamaica, Mexico, Nicaragua, Peru, Poland, Spain, United Kingdom, and Venezuela. Reckitt/Mead Johnson Nutrition has indicated to FDA that the company has already contacted the regulatory authorities in each of the countries to determine the proper disposition of these products.


Constituent Update

December 31, 2023

Today, the U.S. Food and Drug Administration (FDA) is alerting parents, caregivers, and health care providers that Reckitt/Mead Johnson Nutrition has voluntarily recalled certain Nutramigen Hypoallergenic Infant Formula Powder products due to possible *Cronobacter sakazakii* contamination. No illnesses have been reported to date in connection with this recall, and it is likely most of the product that was distributed in the U.S. has already been consumed.

Consumers who have Nutramigen Hypoallergenic Infant Formula Powder with batch codes below should stop using it and throw it away or contact Reckitt/Mead Johnson Nutrition for a refund:

ZL3FHG (12.6 oz cans)
ZL3FMH (12.6 oz cans)
ZL3FPE (12.6 oz cans)
ZL3FQD (12.6 oz cans)
ZL3FRW (19.8 oz cans)
ZL3FXJ (12.6 oz cans)*The products have a UPC Code of 300871239418 or 300871239456 and “Use By Date” of 1 Jan 2025.*

Nutramigen Hypoallergenic Infant Formula Powder - December 2023 Recall
Additional Recall Information

Nutramigen is a hypoallergenic infant formula that is used by infants with allergies to cow’s milk. Although this product is a specialty infant formula, there are substitute infant formulas available. If the infant formula your child uses is unavailable, parents and caregivers should work with their child’s health care provider to find a suitable substitute. The FDA does not expect that this recall will have a major impact on the U.S. supply and availability of powdered infant formulas, and the agency has been in communication with other manufacturers to request their assistance in ensuring a robust supply of hypoallergenic product.

*Cronobacter sakazakii*is a pathogen found naturally in the environment that can enter manufacturing facilities and home environments on hands, shoes, and other contaminated surfaces. While infant formula firms are required to test a representative sample of their product for both *Cronobacter* and *Salmonella* species, this important verification step does not guarantee the product is free of Cronobacter. Cronobacter contamination can occur at very low-levels and is not evenly distributed throughout the product, making it difficult to detect. Powdered infant formula is not a sterile product and public health agencies, including the FDA, encourage caregivers to take steps to prepare powdered infant formula as safely as possible.

The Israeli Ministry of Health notified the FDA on Dec. 14 that Nutramigen Hypoallergenic Powdered Infant Formula produced at the Mead Johnson Nutrition Zeeland, Michigan, facility, and exported from the U.S., had initially tested positive for *Cronobacter*species. The product was tested at the Israeli border during routine sampling. The FDA did not have sufficient information based on this initial test alone to warrant a product action and immediately took additional investigative steps.In consultation with the FDA, Israel initiated whole genome sequencing (WGS) on the sample obtained from the infant formula to confirm the initial findings of *Cronobacter* species and to determine whether the isolate was *Cronobacter sakazakii*.

The FDA immediately commenced a for-cause inspection at Reckitt/Mead Johnson Nutrition's Zeeland facility on Dec. 18 that included collecting environmental samples as well as testing additional samples of finished product from the same batch of Nutramigen infant formula powder tested by Israel. While the FDA’s inspection is ongoing, all testing conducted to date by the FDA and Reckitt/Mead Johnson Nutrition has been negative for *Cronobacter*.

On Dec. 28, the FDA received the WGS results from Israeli health officials, which confirmed a finding of *Cronobacter sakazakii*. The FDA immediately contacted Mead Johnson Nutrition and recommended a recall.

On Dec. 29, Reckitt/Mead Johnson Nutrition agreed to initiate a voluntary recall of 675,030 cans of Nutramigen powdered infant formula distributed to the United States. Reckitt/Mead Johnson Nutrition manufactured additional products during this finished product campaign and distributed them outside of the U.S. Reckitt/Mead Johnson Nutrition will be contacting the regulatory authorities in each of those countries to determine the proper disposition of those products.

The FDA has taken numerous steps to enhance the safety of powdered infant formula through the development of a Cronobacter prevention strategy, enhanced inspectional activities, increased engagement with the infant formula industry, and by pursuing regulatory action when appropriate. The agency also sent a letter to manufacturers, packers, distributors, exporters, importers, and retailers involved in the manufacturing and distribution of powdered infant formula to share current safety information and call on the industry to take prompt action to improve processes and programs for the protection of our most vulnerable population.

The agency remains committed to helping ensure an adequate supply of infant formula and giving consumers the utmost confidence that infant formula available in the U.S. is safe and nutritious.

Additional Resources

Recall Announcement
	Government of Canada Recall Announcement
	Infant Formula
	Status Updates on FDA’s Infant Formula Response Activities

                                                                                  Content current as of:
      01/10/2024
              
              
Regulated Product(s)
		 Food & Beverages
			  			     			  						              
			
			
			
			
			
						  Infant Formula & FoodsCFSAN Constituent Updates
 Subscribe to CFSAN Constituent Updates
                        Get email updates delivered to your inbox.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop